Literature DB >> 16810836

Acquired Haemolytic Anaemia: Survival of Transfused Erythrocytes in Patients and Normal Recipients.

J G Selwyn1, W E Hackett.   

Abstract

Entities:  

Keywords:  ANEMIA/hemolytic; ERYTHROCYTES/viability

Mesh：

Year:  1949        PMID： 16810836      PMCID： PMC1023243          DOI： 10.1136/jcp.2.2.114

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  1 in total

1.  THE IN VITRO PRESERVATION AND POST-TRANSFUSION SURVIVAL OF STORED BLOOD.

Authors:  J F Ross; C A Finch; W C Peacock; M E Sammons
Journal:  J Clin Invest       Date:  1947-07       Impact factor: 14.808
  1 in total
  6 in total

1.  QUANTITATIVE STUDIES OF THE EFFECT OF RED-BLOOD-CELL SENSITIZATION ON IN VIVO HEMOLYSIS.

Authors:  M CONSTANTOULAKIS; N COSTEA; R S SCHWARTZ; W DAMESHEK
Journal:  J Clin Invest       Date:  1963-11       Impact factor: 14.808

2.  Blood-group antibodies and red-cell destruction.

Authors:  P L MOLLISON
Journal:  Br Med J       Date:  1959-11-28

3.  The survival of transfused red cells in acute rheumatic fever with reference to a latent haemolytic mechanism.

Authors:  J REINHOLD
Journal:  Arch Dis Child       Date:  1954-06       Impact factor: 3.791

4.  Acute idiopathic haemolytic anemia.

Authors:  J G MILLICHAP
Journal:  Arch Dis Child       Date:  1952-06       Impact factor: 3.791

5.  Erythrocyte survival in normal mice and in mice with autoimmune haemolytic anaemia.

Authors:  E S Lindsey; G W Donaldson; M F Woodruff
Journal:  Clin Exp Immunol       Date:  1966-01       Impact factor: 4.330

6.  Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.

Authors:  A D Schreiber; M M Frank
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.